Abstract
The metal complex formation properties of the naturally-occurring hydroxamate-type siderophore Desferrioxamine B is surveyed with special emphasis on its solution speciation. The most likely binding-modes of the complexes formed with this ambidentate ligand are also evaluated. A brief survey of the implications of metal chelation in the therapeutic role of DFB in the treatment of metal overloads is also given.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
R.R. Crichton: Inorganic Biochemistry of Iron Metabolism, pp. 173–190, Ellis Horwood, New York (1991).
J.P. Day: Aluminium and other Trace Elements in Renal Disease, (Ed. A. Taylor), pp. 184–191, Baliére Tindall, Eastbourne (1986).
P.A.G. Hammersley: Eur. J. Nucl. Med. 9, 467 (1984).
M.T. Beck and I. Nagypal: Chemistry of Complex Equilibria, p. 49, Akadémiai Kiadó, Budapest, Ellis Horwood, Chichester (1990).
G. Schwarzenbach and K. Schwarzenbach: Helv. Chem. Acta 154, 1390 (1963).
A. Evers, R.D. Hancock, A.E. Martell, and R.J. Motekaitis: Inorg. Chem. 28, 2189 (1989).
B.J. Hernlem, L.M. Vane, and G.D. Sayles: Inorg. Chim. Acta 244, 179 (1996).
E. Farkas, H. Csóka, G. Micera, and A. Dessi: J. Inorg. Biochem. 65, 28l (1997).
P. Buglyó, N. Culeddu, T. Kiss, G. Micera, and D. Sanna: J. Inorg. Biochem. 60, 45 (1995).
G. Anderegg, F. L'Eplattenier, und G. Schawarzenbach: Helv. Chim. Acta 46, 100 (1963).
B. Kurzak, H. Kozlowski, and E. Farkas: Coord. Chem. Rev. 114, 169 (1992).
R.M. Smith and A.E. Martell: Critical Stability Constants, Vol 4, p. 7, Plenum, New York (1976).
W.R. Harris, G. Berthon, J.P. Day, C. Exley, T.P. Flaten, W.F. Forbes, T. Kiss, C. Orvig, and P.F. Zatta: J. Toxicol. Environ. Health 48, 543 (1996).
A.L. Crumbliss: Handbook of Microbial Iron Chelates, (Ed. G. Winkelmann), Ch. 7, CRC Press, Boca Raton (1991).
A.E. Martell and R.M. Smith: Critical Stability Constants, Vols. 1–5, Plenum, New York (1974–82).
M. Birus, Z. Bradic, N. Kujundzic, and M. Pribanic: Inorg. Chim. Acta 56, L43 (1981) and Inorg. Chim. Acta 78, 87 (1983).
E. Farkas, E.A. Enyedi, and H. Csóka: J. Chem. Soc. Dalton Trans. (submitted for publication)
H. Irving and R.J.P Williams: J. Chem. Soc. 3192 (1953).
K.N. Raymond, G. Müller, and B.F. Matzanke: Topics in Current Chemistry, Vol.123, p. 86, Springer-Verlag (1984).
B. Borgias, A.d. Hugi, and K.N. Raymond: Inorg. Chem. 28, 3538 (1989).
B. Monzyk and A.L. Crumbliss: J. Am. Chem. Soc. 104, 4921 (1982).
M. Birus, Z. Bradic, N. Kujundzic, and M. Pribanic: Inorg. Chem. 23, 2170 (1984).
M. Birus, Z. Bradic, G. Krznaric, N. Kujundzic, M. Pribanic, P.C. Wilkins, and R.G. Wilkins: Inorg. Chem. 26, 1000 (1987).
R.J. Keller, J.D. Rush, and T.A. Grover: J. Inorg. Biochem. 41, 269 (1991).
I. Batinic-Haberle, M. Birus, and M. Pribanic: Inorg. Chem. 30, 4882 (1991).
I. Batinic-Haberle, M. Birus, and M. Pribanic: Croat. Chem. Acta 60, 279 (1987).
M. Branca, G. Micera, A. Dessi, D. Sanna, and K.N. Raymond: Inorg. Chem. 29,1586 (1990).
R.R. Crichton: Inorganic Biochemistry of Iron Metabolism, pp. 178–189, Ellis Horwood, New York (1991).
H.P. Schnebli: The Chemistry of Metals in Medicine – The Industrial Perspective, COST D8 Workshop, Louvain-la-Neuve (1997).
P. Ackrill, A.J. Ralston, J.P. Day, and K.C. Hodge: Lancet ii, 692 (1980).
J.P. Day: Aluminium and other Trace Elements in Renal Disease (Ed. A. Taylor), pp. 184–191, Baliére Tindall, Eastbourne, (1986).
D.R. McLachlan, A.J. Dalton, T.P.A. Kruck, M.Y. Bell, W.L. Smith, W. Karlow, and D.F. Andrews: Lancet 337, 1061 (1991).
M.A. Santos, C. Bento, M.A. Erteves, J.P.S. Farinka, and J.M.G. Martinko: Inorg. Chim. Acta 258, 39 (1997).
A.M. Albrecht-Gary, J. Libman, and A. Shanzer: Pure Appl. Chem. 68, 1243 (1996).
Rights and permissions
About this article
Cite this article
Kiss, T., Farkas, E. Metal-binding Ability of Desferrioxamine B. Journal of Inclusion Phenomena 32, 385–403 (1998). https://doi.org/10.1023/A:1008046330815
Issue Date:
DOI: https://doi.org/10.1023/A:1008046330815